Tumor angiogenesis, which is an important component in the development of metastases, has been targeted by inhibition of pro-angiogenic factors, including vascular endothelial growth factor (VEGF) and tyrosine kinases, in both lung and endometrial cancer [3]. Here, VEGFA is linked to neoplasm.